trending Market Intelligence /marketintelligence/en/news-insights/trending/h924gnapp20rl-9uiye91q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Shandong Xinhua Pharmaceutical adds independent nonexecutive director

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Shandong Xinhua Pharmaceutical adds independent nonexecutive director

Shandong Xinhua Pharmaceutical Co. Ltd. shareholders elected Lo Wah Wai as an independent nonexecutive director at their annual general meeting.

Lo is a director at BMI Consultants Ltd., independent nonexecutive director at Chongqing Machinery & Electric Co. Ltd. and Tenfu (Cayman) Holdings Co. Ltd., as well as outside director at Fasteps Co. Ltd.

He succeeds Chan Chung Kik, who resigned to focus on his other business commitments.

China-based Shandong Xinhua Pharmaceutical sells bulk pharmaceuticals, preparations and chemical products.